Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects

SIMPLE SUMMARY: The prognosis and treatment of metastatic melanoma have changed substantially since the advent of target therapy and immune checkpoint inhibitors. Thus, strategies must be developed to identify responder patients, reduce toxicities, and investigate target and immune based therapy ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilla, Lorenzo, Alberti, Andrea, Di Mauro, Pierluigi, Gemelli, Maria, Cogliati, Viola, Cazzaniga, Marina Elena, Bidoli, Paolo, Maccalli, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699774/
https://www.ncbi.nlm.nih.gov/pubmed/33233603
http://dx.doi.org/10.3390/cancers12113456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699774/
https://www.ncbi.nlm.nih.gov/pubmed/33233603
http://dx.doi.org/10.3390/cancers12113456

Ejemplares similares